Suppr超能文献

症状性视神经胶质瘤患者治疗中的确定性放射治疗。生存情况及长期影响。

Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects.

作者信息

Pierce S M, Barnes P D, Loeffler J S, McGinn C, Tarbell N J

机构信息

Department of Radiation Therapy, Harvard Medical School, Boston, MA 02115.

出版信息

Cancer. 1990 Jan 1;65(1):45-52. doi: 10.1002/1097-0142(19900101)65:1<45::aid-cncr2820650111>3.0.co;2-z.

Abstract

We reviewed 24 children who had symptomatic gliomas that involved the optic chiasm and were treated with definitive radiation therapy from 1971 to 1986. In eight patients (33%), histologic confirmation of low-grade astrocytoma was obtained. Patients had radiation therapy only if there was evidence of visual deterioration or other clinical or radiographic evidence of disease progression. Radiation doses ranged from 4500 to 5660 cGy (median, 5400 cGy) with up to a 17-year follow-up period (median, 6 years). The 6-year actuarial freedom from disease progression and overall 6-year survival are 88% and 100%, respectively. Visual improvement or stabilization was seen in 21 (91%) patients after radiation. A high incidence of endocrine abnormalities is reported, with 15 of the 18 patients evaluated after treatment showing growth hormone deficiency. We conclude that definitive radiation therapy is associated with tumor control in most of the patients with progressive optic chiasm gliomas. However, neuropsychiatric and endocrine abnormalities are significant problems that need additional evaluation in these children.

摘要

我们回顾了1971年至1986年间接受确定性放射治疗的24例患有累及视交叉的症状性胶质瘤的儿童。8例患者(33%)获得了低级别星形细胞瘤的组织学确诊。仅在有视力恶化证据或其他疾病进展的临床或影像学证据时,患者才接受放射治疗。放射剂量范围为4500至5660 cGy(中位数为5400 cGy),随访期长达17年(中位数为6年)。6年无疾病进展的精算生存率和总体6年生存率分别为88%和100%。放疗后21例(91%)患者视力改善或稳定。报告内分泌异常的发生率较高,治疗后接受评估的18例患者中有15例出现生长激素缺乏。我们得出结论,对于大多数进行性视交叉胶质瘤患者,确定性放射治疗与肿瘤控制相关。然而,神经精神和内分泌异常是这些儿童中需要进一步评估的重要问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验